Vertex Pharmaceuticals, Inc.
(NASDAQ : VRTX)

( )
VRTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 1.59%182.510.7%$1411.48m
MRKMerck & Co., Inc. 1.39%93.280.7%$1241.52m
PFEPfizer Inc. 3.21%51.700.9%$1234.19m
BMYBristol-Myers Squibb Co. 1.67%78.991.0%$1137.41m
LLYEli Lilly & Co. 4.15%325.691.1%$1136.04m
ABBVAbbVie, Inc. 2.07%152.551.9%$1019.26m
AZNAstraZeneca Plc 3.80%66.901.0%$452.09m
SGENSeagen Inc. 3.06%179.335.7%$326.01m
GSKGSK Plc 2.20%43.690.2%$297.44m
TPTXTurning Point Therapeutics, Inc. 0.03%75.170.0%$291.93m
SIGASIGA Technologies, Inc. -0.46%13.040.0%$219.68m
MRTXMirati Therapeutics, Inc. 3.45%68.161.6%$199.41m
HZNPHorizon Therapeutics Plc 2.68%85.135.4%$182.59m
NVSNovartis AG 3.62%84.820.2%$167.75m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.14%144.000.0%$147.86m

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.